FDA Welcomes New Acting CEO: Homeopathic Association Cheers Appointment
Homeopathic Practitioners Laud Professor Frimpong-Manso’s Expertise
The Homeopathic Practitioners Association of Ghana has expressed strong support for Professor Kwabena Frimpong-Manso following his appointment as the Acting Chief Executive Officer of the Food and Drugs Authority (FDA). The association views this as a significant advancement for healthcare in Ghana.
A Leader for Transformative Change
Adu Boateng, National President of the Homeopathic Practitioners Association, voiced the group’s confidence in Professor Frimpong-Manso’s capacity to modernize the FDA. He highlighted the new CEO’s extensive experience, deep knowledge, and forward-thinking leadership as key assets.
“The COVID-19 pandemic taught us that regulatory bodies must be both vigilant and adaptable – qualities Professor Frimpong-Manso has consistently demonstrated throughout his career,” stated Dr Boateng. “As a renowned academic and regulatory expert, Professor Frimpong-Manso is uniquely positioned to bridge the gap between conventional and alternative medicine.”
Public Health at a Critical Juncture
Dr Boateng emphasized that Professor Frimpong-Manso assumes leadership during a crucial period for national public health. His distinguished career in pharmaceutical sciences and public health is considered highly relevant to the current need for stringent regulatory oversight, unwavering commitment to safety, and innovation in medicine.
The appointment has been met with enthusiasm from various sectors, including health, pharmaceuticals, and traditional medicine. Anticipations are high for tangible improvements in regulatory policies, quality assurance, and a renewed public trust in food and drug safety.
Support from Leadership
The leadership of the Homeopathic Practitioners Association, including Vice President Dr Alex Kwame Appiah and Secretary Dr Ackah, stands in solidarity with the appointment. They are optimistic about the positive impact Professor Frimpong-Manso will have on Ghana’s regulatory landscape.
The association reaffirmed its dedication to fostering collaborative progress within the healthcare sector. The appointment of Professor Frimpong-Manso is seen as a step towards strengthening Ghana’s public health infrastructure. For instance, in 2023, Ghana’s pharmaceutical market was valued at approximately USD 1.1 billion, underscoring the importance of effective regulatory oversight (source: Statista).
